JAK2 and myeloproliferative neoplasm: To determine whether JAK2 mutation-positive MPN might also originate in utero yet present clinically decades later, we carried out JAK2V617F mutation analysis of neonatal blood spots stored from patients subsequently diagnosed with MPN as adults.